SG/CALL/SYNOPSYS/700/0.1/19.09.25 Stock

DE000SU2YXP9

Market Closed - Boerse Frankfurt Warrants 15:35:37 2024-06-28 EDT
7.13 ^EUR	+0.42%

1 month	-0.56%
3 months	-10.76%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart SYNOPSYS INC.

Latest news about SYNOPSYS INC.

Tech boom leads global markets through first half of 2024	06-28	RE
Synopsys Insider Sold Shares Worth $6,656,975, According to a Recent SEC Filing	06-28	MT
KeyBanc Adjusts Price Target on Synopsys to $690 From $675, Maintains Overweight Rating	06-27	MT
Synopsys Insider Sold Shares Worth $4,050,912, According to a Recent SEC Filing	06-26	MT

More news

Quotes 5-day view

Date	Price	Change
24-06-28	7.13	+0.42%
24-06-27	7.1	-0.42%
24-06-26	7.13	+0.42%
24-06-25	7.1	-1.11%
24-06-24	7.18	-6.99%

Real-time Boerse Frankfurt Warrants

Last update June 28, 2024 at 03:35 pm

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	CALL
Underlying	SYNOPSYS INC.
Issuer	Société Générale
WKN	SU2YXP
ISIN	DE000SU2YXP9
Date issued	2023-11-29
Strike	700 $
Maturity	2025-09-19 (446 Days)
Parity	10 : 1
Emission price	6.89 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	10.14 €
Lowest since issue	4.13 €
Spread	0.07 €
Spread %	0.97%

Company Profile

Synopsys Inc. specializes in the development and marketing of software programs aimed mainly at manufacturers of semi-conductors, computers and electronic equipment. Net sales break down by activity as follows: - sale of software and hardware (82.4%): sale of software for the automation of integrated circuit design, pre-designed circuits for semiconductors, software and hardware for the validation of electronic systems, etc.; - provision of services (17.6%): consulting, maintenance and technical assistance services in the areas of software security, quality and compliance. Net sales are distributed geographically as follows: the United States (47.7%), China (15.2%), Korea (10.9%), Europe (10.2%) and other (16%).

Sector

More about the company